HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management.

AbstractINTRODUCTION:
Although opioids are widely prescribed for pain, in many circumstances, they have only modest efficacy. Preclinical studies have shown that chemokines, immune mediators released during tissue injury and inflammation, can desensitize opioid receptors and block opioid analgesia by a process termed "heterologous desensitization." The present studies tested the hypothesis that in evoked pain, certain chemokine receptor antagonists (CRAs), given with a submaximal dose of morphine, would result in enhanced morphine potency.
METHODS:
Three rodent pain assays were used: incisional pain in rats, the cold-water tail flick test in rats, and the formalin test in mice. The FDA-approved, commercially available CRAs, maraviroc and AMD3100, were used. They block the chemokine receptors and ligands, CCR5/CCL5 (RANTES) and CXCR4/CXCL4 (SDF-1α), respectively.
RESULTS:
In the incisional pain assay, it was found that the combination of a single CRA, or of both CRAs, with morphine significantly shifted the morphine dose-response curve to the left, as much as 3.3-fold. In the cold-water tail flick and formalin tests, significant increases of the antinociceptive effects of morphine were also observed when combined with CRAs.
CONCLUSIONS:
These results support the potential of a new "opioid-sparing" approach for pain treatment, which combines CRAs with reduced doses of morphine.
AuthorsToby K Eisenstein, Xiaohong Chen, Saadet Inan, Joseph J Meissler, Christopher S Tallarida, Ellen B Geller, Scott M Rawls, Alan Cowan, Martin W Adler
JournalMilitary medicine (Mil Med) Vol. 185 Issue Suppl 1 Pg. 130-135 (01 07 2020) ISSN: 1930-613X [Electronic] England
PMID32074321 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© Association of Military Surgeons of the United States 2020. All rights reserved. For permissions, please e-mail: [email protected].
Chemical References
  • Analgesics, Opioid
  • Benzylamines
  • Cyclams
  • Drug Combinations
  • Heterocyclic Compounds
  • Receptors, Chemokine
  • Morphine
  • Maraviroc
  • plerixafor
Topics
  • Analgesics, Opioid (pharmacology, therapeutic use)
  • Analysis of Variance
  • Animals
  • Benzylamines
  • Cyclams
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Heterocyclic Compounds (pharmacology, therapeutic use)
  • Maraviroc (pharmacology, therapeutic use)
  • Morphine (pharmacology, therapeutic use)
  • Pain Management (methods, standards, statistics & numerical data)
  • Pain Measurement (methods)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Chemokine (antagonists & inhibitors)
  • Surgical Wound (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: